Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Respiratory Medicine Case Reports
|
May 26, 2016
Immunomodulatory effect of macrolides: At what cost?
Maria Kipourou, Katerina Manika, Apostolos Papavasileiou, et al.
Oxford Medical Case Reports
|
September 30, 2020
18F-FDG PET/CT contribution to tuberculous vertebral osteomyelitis diagnosis: a case report
Katerina Manika, Maria Kipourou, Stamata Georga, et al.
Antibiotics (Basel, Switzerland)
|
February 25, 2023
Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
Maria Kipourou, Olga Begou, Katerina Manika, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 28, 2025
Managing Small Airways Dysfunction in COPD Patients in Real Life Under Fixed Triple Combination of Beclomethasone/Formoterol/Glycopyrronium: The MASCOT Real World Evidence Study
Athena Gogali, Konstantinos Kostikas, Christos Kyriakopoulos, et al.
Oncotargets and Therapy
|
November 1, 2013
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
Konstantinos Zarogoulidis, Efimia Boutsikou, Paul Zarogoulidis, et al.
Journal of Thoracic Disease
|
March 17, 2015
Open thoracotomy for pneumothorax
Achilleas Lazopoulos, Nikolaos Barbetakis, George Lazaridis, et al.
Journal of Thoracic Disease
|
March 17, 2015
Pneumomediastinum
Vasileios K Kouritas, Konstantinos Papagiannopoulos, George Lazaridis, et al.
International Archives of Allergy and Immunology
|
June 23, 2020
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis
Maria Kallieri, Eleftherios Zervas, Konstantinos Katsoulis, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 12, 2023
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
Maria Kallieri, Andriana I Papaioannou, Eleftherios Zervas, et al.
Allergy
|
May 20, 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response
Maria Kallieri, Eleftherios Zervas, Evangelia Fouka, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Respiratory Medicine Case Reports
|
May 26, 2016
Immunomodulatory effect of macrolides: At what cost?
Maria Kipourou, Katerina Manika, Apostolos Papavasileiou, et al.
Oxford Medical Case Reports
|
September 30, 2020
18F-FDG PET/CT contribution to tuberculous vertebral osteomyelitis diagnosis: a case report
Katerina Manika, Maria Kipourou, Stamata Georga, et al.
Antibiotics (Basel, Switzerland)
|
February 25, 2023
Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
Maria Kipourou, Olga Begou, Katerina Manika, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 28, 2025
Managing Small Airways Dysfunction in COPD Patients in Real Life Under Fixed Triple Combination of Beclomethasone/Formoterol/Glycopyrronium: The MASCOT Real World Evidence Study
Athena Gogali, Konstantinos Kostikas, Christos Kyriakopoulos, et al.
Oncotargets and Therapy
|
November 1, 2013
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
Konstantinos Zarogoulidis, Efimia Boutsikou, Paul Zarogoulidis, et al.
Journal of Thoracic Disease
|
March 17, 2015
Open thoracotomy for pneumothorax
Achilleas Lazopoulos, Nikolaos Barbetakis, George Lazaridis, et al.
Journal of Thoracic Disease
|
March 17, 2015
Pneumomediastinum
Vasileios K Kouritas, Konstantinos Papagiannopoulos, George Lazaridis, et al.
International Archives of Allergy and Immunology
|
June 23, 2020
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis
Maria Kallieri, Eleftherios Zervas, Konstantinos Katsoulis, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 12, 2023
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
Maria Kallieri, Andriana I Papaioannou, Eleftherios Zervas, et al.
Allergy
|
May 20, 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response
Maria Kallieri, Eleftherios Zervas, Evangelia Fouka, et al.
Page
of 3